Cargando…
Sirolimus for treatment of kaposiform hemangioendothelioma associated with Kasabach-Merritt phenomenon
Autores principales: | Alaqeel, Alaa M., Alfurayh, Nuha A., Alhedyani, Alanoud A., Alajlan, Saad M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148769/ https://www.ncbi.nlm.nih.gov/pubmed/27981218 http://dx.doi.org/10.1016/j.jdcr.2016.06.005 |
Ejemplares similares
-
Sirolimus for Kaposiform Hemangioendothelioma and Kasabach-Merritt Phenomenon in a Neonate
por: Cabrera, Trevor B., et al.
Publicado: (2020) -
Kaposiform hemangioendothelioma with fatal income: Kasabach–Merritt phenomenon and hypercalcemia
por: Massara, Baklouti, et al.
Publicado: (2022) -
Kaposiform hemangioendothelioma complicated by Kasabach–Merritt phenomenon in an infant girl
por: Helligsø, Louise, et al.
Publicado: (2023) -
Pancreatic kaposiform hemangioendothelioma complicated by Kasabach–Merritt phenomenon: A rare entity
por: Mathew, Denny, et al.
Publicado: (2019) -
The importance of early diagnosis and treatment of kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon
por: Vivas-Colmenares, Grecia V., et al.
Publicado: (2015)